WallStreetZenWallStreetZen

NASDAQ: FHTX
Foghorn Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for FHTX

Based on 3 analysts offering 12 month price targets for Foghorn Therapeutics Inc

Min Forecast
$11.00+109.13%
Avg Forecast
$11.67+121.81%
Max Forecast
$12.00+128.14%

Should I buy or sell FHTX stock?

Based on 3 analysts offering ratings for Foghorn Therapeutics Inc.

Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their FHTX stock forecasts and price targets.

FHTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-18
lockedlocked$00.00+00.00%2025-12-04
lockedlocked$00.00+00.00%2025-11-07

1 of 1

Forecast return on equity

Is FHTX forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is FHTX forecast to generate an efficient return on assets?

Company
-16.23%
Industry
119.18%
FHTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

FHTX earnings per share forecast

What is FHTX's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
-$1.08
Avg 2 year Forecast
-$1.12
Avg 3 year Forecast
-$0.81

FHTX revenue forecast

What is FHTX's revenue in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$35.6M+45.33%
Avg 2 year Forecast
$40.9M+66.91%
Avg 3 year Forecast
$58.9M+140.34%
FHTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FHTX revenue growth forecast

How is FHTX forecast to perform vs Biotechnology companies and vs the US market?

Company
31.44%
Industry
112.96%
Market
23%
FHTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FHTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FHTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FHTX$5.26$11.67+121.81%Strong Buy
AARD$13.70$28.71+109.59%Strong Buy
NGNE$19.12$70.00+266.11%Buy
PALI$2.02$18.50+815.84%Strong Buy
LRMR$3.42$14.25+316.67%Buy
View Top Biotech Stocks

Foghorn Therapeutics Stock Forecast FAQ

Is Foghorn Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: FHTX) stock is to Strong Buy FHTX stock.

Out of 3 analysts, 3 (100%) are recommending FHTX as a Strong Buy, 0 (0%) are recommending FHTX as a Buy, 0 (0%) are recommending FHTX as a Hold, 0 (0%) are recommending FHTX as a Sell, and 0 (0%) are recommending FHTX as a Strong Sell.

If you're new to stock investing, here's how to buy Foghorn Therapeutics stock.

What is FHTX's earnings growth forecast for 2026-2028?

(NASDAQ: FHTX) Foghorn Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.83%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.6%.

Foghorn Therapeutics's earnings in 2026 is -$72,122,000.On average, 12 Wall Street analysts forecast FHTX's earnings for 2026 to be -$60,871,807, with the lowest FHTX earnings forecast at -$85,403,757, and the highest FHTX earnings forecast at -$43,346,563. On average, 11 Wall Street analysts forecast FHTX's earnings for 2027 to be -$63,082,963, with the lowest FHTX earnings forecast at -$97,539,663, and the highest FHTX earnings forecast at -$42,158,986.

In 2028, FHTX is forecast to generate -$45,800,889 in earnings, with the lowest earnings forecast at -$68,166,924 and the highest earnings forecast at -$20,188,810.

What is FHTX's revenue growth forecast for 2026-2028?

(NASDAQ: FHTX) Foghorn Therapeutics's forecast annual revenue growth rate of 31.44% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 112.96%, and while it is forecast to beat the US market's average forecast revenue growth rate of 23%.

Foghorn Therapeutics's revenue in 2026 is $24,518,000.On average, 12 Wall Street analysts forecast FHTX's revenue for 2026 to be $2,014,978,978, with the lowest FHTX revenue forecast at $0, and the highest FHTX revenue forecast at $3,562,731,207. On average, 12 Wall Street analysts forecast FHTX's revenue for 2027 to be $2,314,304,951, with the lowest FHTX revenue forecast at $1,108,405,264, and the highest FHTX revenue forecast at $3,633,985,831.

In 2028, FHTX is forecast to generate $3,332,341,256 in revenue, with the lowest revenue forecast at $1,385,506,581 and the highest revenue forecast at $4,871,610,791.

What is FHTX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: FHTX) forecast ROA is -16.23%, which is lower than the forecast US Biotechnology industry average of 119.18%.

What is FHTX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year FHTX price target, the average FHTX price target is $11.67, with the highest FHTX stock price forecast at $12.00 and the lowest FHTX stock price forecast at $11.00.

On average, Wall Street analysts predict that Foghorn Therapeutics's share price could reach $11.67 by Dec 18, 2026. The average Foghorn Therapeutics stock price prediction forecasts a potential upside of 121.81% from the current FHTX share price of $5.26.

What is FHTX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: FHTX) Foghorn Therapeutics's current Earnings Per Share (EPS) is -$1.13. On average, analysts forecast that FHTX's EPS will be -$1.08 for 2026, with the lowest EPS forecast at -$1.51, and the highest EPS forecast at -$0.77. On average, analysts forecast that FHTX's EPS will be -$1.12 for 2027, with the lowest EPS forecast at -$1.72, and the highest EPS forecast at -$0.75. In 2028, FHTX's EPS is forecast to hit -$0.81 (min: -$1.21, max: -$0.36).

What is FHTX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: FHTX) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.